ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

SRPT Sarepta Therapeutics Inc New

130.63
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Sarepta Therapeutics Inc New SRPT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 130.63 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
130.63
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202415:05BWSarepta Therapeutics Announces First Quarter 2024 Financial..
30/4/202417:38BWSarepta Therapeutics Announces Inducement Grants Under..
24/4/202407:30BWSarepta Therapeutics to Announce First Quarter 2024..
29/3/202415:00BWSarepta Therapeutics Announces Inducement Grants Under..
08/3/202416:38EDGAR2Form 144 - Report of proposed sale of securities
06/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202416:34EDGAR2Form 144 - Report of proposed sale of securities
04/3/202407:30BWSarepta Therapeutics to Present at Upcoming Investor..
01/3/202418:55EDGAR2Form 144 - Report of proposed sale of securities
01/3/202418:42EDGAR2Form 144 - Report of proposed sale of securities
01/3/202415:47EDGAR2Form 144 - Report of proposed sale of securities
29/2/202417:16BWSarepta Therapeutics Announces Inducement Grants Under..
29/2/202408:00BWSarepta Therapeutics Announces Call for Applications for the..
28/2/202415:05BWSarepta Therapeutics Announces Fourth Quarter and Full-Year..
21/2/202407:30BWSarepta Therapeutics to Announce Fourth Quarter and..
16/2/202406:00BWSarepta Therapeutics Announces U.S. FDA Acceptance of an..
13/2/202412:34EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202417:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
31/1/202417:29BWSarepta Therapeutics Announces Inducement Grants Under..
29/1/202406:00BWSarepta Therapeutics Announces Positive Data from Part B of..
16/1/202408:02BWSarepta Therapeutics Initiates Screening in EMERGENE, a..
08/1/202411:08EDGAR2Form 8-K - Current report
08/1/202410:55BWSarepta Therapeutics Reports Preliminary* Fourth Quarter and..
02/1/202407:30BWSarepta Therapeutics to Present at the 42nd Annual J.P...
29/12/202317:27BWSarepta Therapeutics Announces Inducement Grants Under..
22/12/202307:00BWSarepta Therapeutics Submits Efficacy Supplement to Expand..
05/12/202319:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202317:34BWSarepta Therapeutics Announces Inducement Grants Under..
20/11/202319:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202307:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202307:30BWSarepta Therapeutics to Present at the UBS Biopharma..
01/11/202315:05BWSarepta Therapeutics Announces Third Quarter 2023 Financial..
01/11/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202318:02BWSarepta Therapeutics Announces Inducement Grants Under..
30/10/202316:17DJNSarepta Therapeutics to Request Expansion of Elevidys to All..

Su Consulta Reciente

Delayed Upgrade Clock